Loading...
Kronos Bio, Inc.
KRON•NASDAQ
HealthcareBiotechnology
$0.87
$0.002(0.24%)
Kronos Bio, Inc. (KRON) Financial Performance & Statements
Review Kronos Bio, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
56.62%
↑ 56.62%
Operating Income Growth
23.76%
↑ 23.76%
Net Income Growth
23.60%
↑ 23.60%
Operating Cash Flow Growth
16.73%
↑ 16.73%
Operating Margin
-765.18%
↓ 765.18%
Gross Margin
100.00%
↑ 100.00%
Net Profit Margin
-701.53%
↓ 701.53%
ROE
-64.22%
↓ 64.22%
ROIC
-70.15%
↓ 70.15%
Kronos Bio, Inc. (KRON) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Kronos Bio, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $2.27M | $2.37M | $2.69M | $2.52M |
| Cost of Revenue | $409000.00 | $0.00 | $420000.00 | $1.27M |
| Gross Profit | $1.86M | $2.37M | $2.27M | $1.25M |
| Gross Profit Ratio | $0.82 | $1.00 | $0.84 | $0.50 |
| R&D Expenses | $8.41M | $12.27M | $13.77M | $13.75M |
| SG&A Expenses | $4.92M | $5.82M | $6.37M | $6.71M |
| Operating Expenses | $29.42M | $18.09M | $20.71M | $20.46M |
| Total Costs & Expenses | $29.42M | $18.09M | $20.71M | $21.73M |
| Interest Income | $1.34M | $1.61M | $1.82M | $2.04M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $2.04M |
| Depreciation & Amortization | $409000.00 | $412000.00 | $420000.00 | $1.27M |
| EBITDA | -$10.65M | -$15.30M | -$17.02M | -$18.73M |
| EBITDA Ratio | -$4.69 | -$6.46 | -$6.33 | -$7.43 |
| Operating Income | -$27.15M | -$15.72M | -$18.02M | -$19.21M |
| Operating Income Ratio | -$11.96 | -$6.63 | -$6.70 | -$7.62 |
| Other Income/Expenses (Net) | $1.34M | $1.61M | $1.82M | $2.04M |
| Income Before Tax | -$25.81M | -$14.11M | -$16.20M | -$29.96M |
| Income Before Tax Ratio | -$11.37 | -$5.95 | -$6.03 | -$11.89 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $1.23M |
| Net Income | -$25.81M | -$14.11M | -$16.20M | -$29.96M |
| Net Income Ratio | -$11.37 | -$5.95 | -$6.03 | -$11.89 |
| EPS | -$0.43 | -$0.23 | -$0.27 | -$0.50 |
| Diluted EPS | -$0.43 | -$0.23 | -$0.27 | -$0.50 |
| Weighted Avg Shares Outstanding | $60.34M | $60.31M | $60.10M | $59.52M |
| Weighted Avg Shares Outstanding (Diluted) | $60.34M | $60.31M | $60.10M | $59.52M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan